AzTrials
AzTrials

DeafnessPSIC-TSANCT04663022

Influence of the Sensory Profile of Deaf Children With Autism Spectrum Disorders on the Outcome of Cochlear Implantation

An observational study of Deafness, run by University Hospital, Toulouse at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An unpublished study conducted at Toulouse University Hospital revealed that 30% of implanted children with Autism Spectrum Disorders abandon their implant, while 70% of them keep it. Read more about this study

Who is it for?
Ages 15 months to 10 years
Conditions the study is for
Deafness
What is being tested?
Dunn's sensory profile questionnaire
How many people
33 participants
Where
1 siteFrance
Study dates
1 Dec 2020to 31 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 months to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Study population is deaf children with cochlear implant. In the first group, children must have cochlear implant and autism spectrum disorders, and in second group, children must have only cochlear implant.

Who may be able to join

  • Deaf child with cochlear implant
  • 15 months to 10 years old and 6 months old at the time of implantation
  • Child with autism spectrum disorder (only for children group with autisme spectrum disorder)
  • No opposition from the legal representative of the authority to participate in the study

Who cannot join

  • Opposition by the legal representative of the child
  • Child under legal protection

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Toulouse

    Toulouse, 31059

Other trials in France

About this study

An unpublished study conducted at Toulouse University Hospital revealed that 30% of implanted children with Autism Spectrum Disorders abandon their implant, while 70% of them keep it. The aim of this study is to evaluate the causes of this disparity, which is much greater than in children with cochlear implants without associated Autism Spectrum Disorders. Our problem is as follows: do the sensory hypersensitivity and hyposensitivity of deaf children with Autism Spectrum Disorders have an effect on the expected results after a cochlear implantation from a language and auditory reaction point of view?

Read the detailed description

The present study will specifically focus on the sensory profile of these children with Autism Spectrum Disorders, which could be the cause of these developmental difficulties in language and communication development.

Conditions
Deafness
Being tested
Dunn's sensory profile questionnaire
Medical subject headings
Deafness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dunn's sensory profile questionnaireOther

    all children will complete the Dunn Sensory Profile questionnaire

Study groups in NCT04663022
Study groupRoleWhat they receive
Child with cochlear implant15 childs with coclear implant but without autism spectrum disorder
Receives: Other: Dunn's sensory profile questionnaire
Child with cochlear implant and autism spectrum disorder15 childs with coclear implant and with autism spectrum disorder
Receives: Other: Dunn's sensory profile questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. determine the sensory profile

    To determine the sensory profile of implanted deaf children with autism spectrum disorders, each parent complete the questionnaire Dunn's sensory profile

    Measured: inclusion visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2020
  2. Study start1 Dec 2020
  3. Primary completion10 May 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04663022
Sponsor's protocol ID
RC31/20/0328
Acronym
PSIC-TSA
Status last verified
Aug 2022
First submitted
3 Dec 2020
Last updated
19 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Deafness, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

determine the sensory profile (time frame: inclusion visit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in